GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

EVH · Mar 31, 2026

Evolent Health, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001628908-26-000033General Corporate
Operating cash generation11thOwn-history percentile · N=9
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-0.20% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

2.60% · CORE · NOT_ENOUGH_HISTORY

Gross margin44thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.gross_margin

16.88% · CORE · VALID

Operating margin33thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.operating_margin

-2.14% · CORE · VALID

SBC intensity44thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

2.15% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History11 statesHistory building
Period transition

What moved in the state?

Cash Generation Decreased
Previous
2.07%
Current
-0.20%
Delta
-2.27%
Growth Increased
Previous
-26.56%
Current
2.60%
Delta
29.16%
Margin Decreased
Previous
21.31%
Current
16.88%
Delta
-4.43%
Profitability Increased
Previous
-21.86%
Current
-2.14%
Delta
19.72%
Sbc Intensity Increased
Previous
2.12%
Current
2.15%
Delta
0.03%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.